Assignee
MERUS NV
NL43 patents
Top patents by PatentIndex Score
US9758805B2Sep 12, 2017
Methods and means for the production of Ig-like molecules
MERUS NV23 citations94
US10605808B2Mar 31, 2020
Antibody producing non-human animals
MERUS NV19 citations91
US9951124B2Apr 24, 2018
Antibody producing non-human mammals
MERUS NV10 citations91
US11279770B2Mar 22, 2022
Antibody that binds ErbB-2 and ErbB-3
MERUS NV7 citations85
US10752929B2Aug 25, 2020
Methods and means for the production of ig-like molecules
MERUS NV5 citations84
US10670599B2Jun 2, 2020
Method for selecting a single cell expressing a heterogeneous combination of antibodies
MERUS NV6 citations84
US10337045B2Jul 2, 2019
Methods and means for the production of Ig-like molecules
MERUS NV3 citations84
US10329596B2Jun 25, 2019
Methods and means for the production of Ig-like molecules
MERUS NV4 citations84
US11237165B2Feb 1, 2022
Antibody producing non-human animals
MERUS NV5 citations83
US10358492B2Jul 23, 2019
Bispecific IgG antibodies as T cell engagers
MERUS NV11 citations83
US10844127B2Nov 24, 2020
Antibodies that bind EGFR and ErbB3
MERUS NV8 citations82
US10647781B2May 12, 2020
Generation of binding molecules
MERUS NV6 citations82
US10266593B2Apr 23, 2019
Human CD3 binding antibody
MERUS NV6 citations82
US9914777B2Mar 13, 2018
Human CD3 binding antibody
MERUS NV11 citations82
US10934571B2Mar 2, 2021
Recombinant production of mixtures of antibodies
MERUS NV4 citations79
US12139548B2Nov 12, 2024
Antibody that binds ErbB-2 and ErbB-3
MERUS NV4 citations74
US12247078B2Mar 11, 2025
ERBB-2 and ERBB-3 binding bispecific antibodies for use in the treatment of cells that have an NRG1 fusion gene
MERUS NV3 citations73
US12123043B2Oct 22, 2024
Methods and means for the production of Ig-like molecules
MERUS NV1 citations73
US11926859B2Mar 12, 2024
Methods and means for the production of Ig-like molecules
MERUS NV2 citations73
US11780925B2Oct 10, 2023
ErbB-2 and ErbB3 binding bispecific antibodies for use in the treatment of cells that have an NRG1 fusion gene
MERUS NV5 citations73
US12195551B2Jan 14, 2025
Combination of an ErbB-2/ErbB-3 bispecific antibody with endocrine therapy for breast cancer
MERUS NV3 citations71
US11820825B2Nov 21, 2023
Methods of treating a subject having an EGFR-positive and/or ErbB-3-positive tumor
MERUS NV2 citations71
US11753470B2Sep 12, 2023
Bispecific anti PD1-anti TIM3 antibodies
MERUS NV2 citations71
US11732043B2Aug 22, 2023
Antibodies that modulate a biological activity expressed by a cell
MERUS NV3 citations71
US11667714B2Jun 6, 2023
Binding molecules that modulate a biological activity expressed by a cell
MERUS NV3 citations71
US11408095B2Aug 9, 2022
Generation of binding molecules
MERUS NV2 citations71
US11559049B2Jan 24, 2023
Antibody producing non-human animals
MERUS NV2 citations70
US11939394B2Mar 26, 2024
Binding molecules that inhibit cancer growth
MERUS NV4 citations66
US11873338B2Jan 16, 2024
CLEC12AxCD3 bispecific antibodies and methods for the treatment of disease
MERUS NV2 citations64
US11952424B2Apr 9, 2024
Multivalent antibody
MERUS NV1 citations62
US11785924B2Oct 17, 2023
Antibody producing non-human animals
MERUS NV0 citations62
US12577306B2Mar 17, 2026
Bispecific anti PD1-anti TIM3 antibodies
MERUS NV0 citations61
US12291798B2May 6, 2025
Generation of binding molecules
MERUS NV0 citations61
US12060418B2Aug 13, 2024
Bispecific IgG antibodies as T cell engagers
MERUS NV0 citations61
US11925174B2Mar 12, 2024
Antibody producing non-human animals
MERUS NV0 citations61
US11739148B2Aug 29, 2023
Human CD3 binding antibody
MERUS NV0 citations61
US11685786B2Jun 27, 2023
Binding molecules that bind CD137 and PD-L1
MERUS NV1 citations61
USRE47770EDec 17, 2019
Recombinant production of mixtures of antibodies
MERUS NV1 citations59
US12503509B2Dec 23, 2025
CLEC12AxCD3 bispecific antibodies and methods for the treatment of disease
MERUS NV0 citations54
US11993654B2May 28, 2024
PD-1 binding domains
MERUS NV1 citations53
US12570747B2Mar 10, 2026
TGF-beta-RII binding proteins
MERUS NV0 citations51
US11773170B2Oct 3, 2023
Antibodies that bind EGFR and cMET
MERUS NV0 citations50
US12460002B2Nov 4, 2025
CD3 binding molecules
MERUS NV0 citations49